These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26097481)

  • 1. Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys.
    Mifsud EJ; Tan AC; Brown LE; Chua BY; Jackson DC
    Front Immunol; 2015; 6():290. PubMed ID: 26097481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
    Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
    Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the impact of influenza-associated secondary pneumococcal infections.
    Mifsud EJ; Tan AC; Short KR; Brown LE; Chua BY; Jackson DC
    Immunol Cell Biol; 2016 Jan; 94(1):101-8. PubMed ID: 26134269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.
    Mifsud EJ; Tan AC; Reading PC; Jackson DC
    Immunol Cell Biol; 2016 Feb; 94(2):169-76. PubMed ID: 26272554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.
    Cobbin JC; Zeng W; Jackson DC; Brown LE
    PLoS One; 2014; 9(12):e115356. PubMed ID: 25522323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
    Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
    Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
    Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
    Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
    Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract.
    Marois I; Cloutier A; Garneau É; Richter MV
    J Leukoc Biol; 2012 Jul; 92(1):107-21. PubMed ID: 22504848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
    Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
    Quan FS; Huang C; Compans RW; Kang SM
    J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.
    Takeshita F; Tanaka T; Matsuda T; Tozuka M; Kobiyama K; Saha S; Matsui K; Ishii KJ; Coban C; Akira S; Ishii N; Suzuki K; Klinman DM; Okuda K; Sasaki S
    J Virol; 2006 Jul; 80(13):6218-24. PubMed ID: 16775309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.